Reading ACU? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ACU free→Reading ACU? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ACU free→AMEXConsumer StaplesHousehold & Personal ProductsSnapshot 2026-06-15
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is neutral, while earnings quality is robust, cash backs up reported profits. Management's recent track record has been steady, and it has a capital-friendly stance. Risk is elevated, and the sector backdrop is a headwind, with ACU trading below typical compared to sector peers. Peer multiples imply a price about 13% below where it trades (it looks expensive on this basis); the read is fair. If ACU cuts guidance on the next call, that could have a meaningful negative impact. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $45.01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $45 ACU trades at 19× p/e, in line with its 17× p/e peer median. Our $40 fair value reflects that, high confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 13% near-term growth, ahead of our forecast of about 2%. This describes what's priced in, not a forecast of the move.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 0 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated neutral grew net income 52% of the time over the next year (vs 61% for the rest of the cohort, n=1526).
Over the trailing year it converted 2.03x of net income into operating cash flow. Historically, Consumer Staples names rated robust grew net income 64% of the time over the next year (vs 51% for the rest of the cohort, n=1037).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.48 → $0.40 (-16.7% / 30d). 0 raised, 1 cut, 1 covering analysts.
0 upgrades, 0 downgrades / 30d. 0% of analysts rate Buy.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$118.
How much price usually moves either way.
On a bad day, this stock has moved -$264.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,005.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Retail sales data can show how much consumers want to buy. This affects Acme United's sales.
Confirms one read:Retail sales increase by more than 1% month over month.
Confirms the other:Retail sales decline by more than 1% month over month.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for ACU yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On April 23, 2026, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this current report.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Household Products.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
ACU Acme United Corp. | Below typical Show detailsSector percentile: 21 of 100 | full | elevated |
CL Colgate-Palmolive | Typical Show detailsSector percentile: 56 of 100 | full | moderate |
KMB Kimberly-Clark | Above typical Show detailsSector percentile: 91 of 100 | fair | moderate |
CHD Church & Dwight | Typical Show detailsSector percentile: 38 of 100 | expensive | low |
CLX Clorox | Above typical Show detailsSector percentile: 73 of 100 | fair | moderate |
5 material management or governance events in the past 24 months, led by M&A activity. Historically, Consumer Staples names rated stable grew net income 53% of the time over the next year (vs 47% for the rest of the cohort, n=379).
Not investment advice. As of 2026-06-15.
via XLP
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Acme United Corp. aims to expand its product offerings by acquiring My Medic, a supplier of tactical and emergency response products.
Newly stated in 2026-Q1. The acquisition of My Medic was announced to enhance product offerings in tactical and emergency response products. This strategic move is expected to contribute to growth, but financial impacts are yet to be reflected in the reported figures.
“On January 15, 2026, Acme United announced the acquisition of My Medic.”
Acme United Corp. continues to maintain a dividend payout of $0.16 per share, reflecting its commitment to returning value to shareholders.
Stated in 4 of last 4 quarters. Dividend per share maintained at $0.16 from 2025-Q2 to 2026-Q1, reflecting consistent capital allocation to shareholders. Despite fluctuations in net income, the company has sustained its dividend commitment.
Acme United Corp. is focused on improving its operating income through cost management and operational efficiencies.
Stated in 3 of last 3 quarters. Operating income decreased to $1.75M in 2026-Q1 from $2.91M in 2025-Q4, indicating limited progress in improving operational efficiency. The company needs to address this decline to meet its stated priority.
Why it matters: If revenue growth picks up, it could signal a stronger market for Acme United Corp. and improve its outlook.
Confirms:The Consumer Staples sector shows revenue growth speeding up to 6% year over year.
Disproves:Sector revenue growth remains below 4% year over year.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On February 26, 2026, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended December 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this current report.
COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS. On January 15, 2026, Acme United Corporation (the “Company”) announced that it had entered into and closed a transaction pursuant to an Asset Purchase Agreement (the “Agreement”) dated January 15, 2026 with SLED Distribution, LLC. d/b/a "My Medic" (“My Medic”), a leading supplier of tactical, trauma and emergency response products, primarily in the direct-to-consumer channel and Rapid Medical, LLC (“Rapid Medical” and, together with My Medic…
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. See the disclosure in
RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 21, 2025, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this current report.
“The company declared a dividend of $0.16 per share for 2026-Q1.”
“The company declared a dividend of $0.16 per share for 2025-Q3.”
“The company declared a dividend of $0.16 per share for 2025-Q2.”
“The company declared a dividend of $0.15 per share for 2024-Q3.”
“Operating income decreased to $1.75M in 2026-Q1 from $2.91M in 2025-Q4.”
“Operating income was $2.91M in 2025-Q4.”
“Operating income was $3.01M in 2025-Q3.”